DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 2.07% to $6.41 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.16% to 16,884.60 and the Dow Jones Industrial Average rising 1.20% to 40,829.59.
The stock's rise snapped a two-day losing streak.
Inovio Pharmaceuticals Inc. closed $8.34 short of its 52-week high ($14.75), which the company reached on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.36% to $166.61, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 2.98% to $29.41.
Trading volume (157,675) remained 235,747 below its 50-day average volume of 393,422.
Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 09, 2024 17:29 ET (21:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。